Fleurish Cannabis Inc. (“Fleurish”), an exclusively female-focused cannabis health and wellness company, is proud to announce the company is now officially licensed as a producer of cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations.

With this licence, Fleurish will begin the cultivation of cannabis strains focused on meeting women’s specific needs at their state-of-the-art facility in Kemptville, Ontario.

“Today represents a significant milestone for Fleurish,” said Renée Ellison, Founder, Fleurish. “With the receipt of our Production Licence from Health Canada, we can now move forward and prepare to provide a cannabis experience crafted uniquely for women.”

Maricann Group Inc. (CSE:MARI; FWB:75M; OTCQB:MRRCF)is excited to announce the official launch of MariPlant, the Company’s European nutraceutical line of business. MariPlant products will be available for sale in Germany through www.mariplant.de beginning on August 20, 2018, with strategic expansion planned throughout the European Union.

The Flowr Group (Okanagan) Inc., a cultivator of premium cannabis in Canada, announced today that it has received its sales license from Health Canada.  The license enables Flowr to sell to the Canadian medical and adult-use recreational markets.

Flowr will begin selling to the medical market in the coming weeks and the recreational market when it opens in October.  Flowr recently was selected by the British Columbia Liquor Distribution Branch to supply premium cannabis to province-owned dispensaries and the company is in discussions with other provinces where it believes it can obtain prices commensurate with the quality of the Flowr products.  The company has agreements in place with several major medical cannabis distributors as well.

 Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that its acquisition of Anandia Laboratories Inc. ("Anandia") is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act (British Columbia), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the "Transaction").

Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.

B.C.’s Liquor Distribution Branch has made its second product call for licensed marijuana growers, adding to the 150 cannabis types it signed up in July to prepare for provincial stores to open in October.

Applications from federally licensed producers of dried cannabis, oils, capsules and seed are being accepted until the end of August, to add to the accepted products from large producers that will stock both private and LDB stores in B.C.

With the legalization of marijuana only two months away, new Statistics Canada data shows urban northerners smoke pot more frequently than their provincial counterparts.

Statistics Canada released the second-quarter results of its National Cannabis Survey on Thursday. It compared data collected from residents in the three northern capitals with those in the 10 provinces.

- IN DEPTH | Cannabis as colonialism? N.W.T. woman says government shouldn't 'impose' legalization

In Spruce Grove, Alta., people camped out by city hall, waiting for the doors to open so they could apply to open a cannabis store.

In other places in the province, retailers are signing leases with rents that are as much as twice the usual rate, in the hope they will eventually win the right to sell marijuana in those locations.

In Ontario, veteran retailer Michael Serruya says he has identified 27 future locations for cannabis shops – even though the province’s new government hasn’t officially said whether it will allow a single privately owned store to sell recreational marijuana.

RioCan Real Estate Investment Trust said it’s anticipating a “gold rush” from Canada’s legalization of recreational marijuana in October, bringing premium rents and boosting demand for retail real estate across the country’s biggest markets.

Canadian pot companies say they’re ready to start building in Ontario if its government allows private stores to sell marijuana, a prospect being considered by the conservative premier, Doug Ford. That system would mark a shift from the previous, liberal government’s decision to leave sales to government entities like the Liquor Control Board of Ontario.

Cannabis is slowly taking root in increasingly tolerant communities. The incremental decriminalization or legalization of cannabis across the world has fed an expanding international market trading the plant, its extracts and its end products.

"2018 has seen a lot of trends in cannabis, but the beginning of an international market infrastructure is one of the most promising features of the industry for investor interest,” AxisWire CEO Cynthia Salarizadeh told Benzinga.

Canadian pets are a few steps closer to getting their paws on pot-based medical treatments in Canada as more cannabis companies research marijuana's efficacy for companion animals.

Canopy Growth Corp. is the latest medical marijuana company to enter the potentially lucrative pet market with its announcement this week that it will embark on a Health Canada-approved clinical trial to research the use of cannabis-based products to treat animal anxiety.

The Canadian Veterinary Medical Association's Dr. Shane Renwick says there's been a flurry of cannabis-related pet health research as Canada's laws on recreational cannabis crystallize ahead of legalization on Oct. 17.